Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Reference32 articles.
1. Levy, D., Byfield, S., Comstock, C., Garber, J., Syngal, S., Crown, W., Shields, A.: Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk. Genet. Med. 13(4), 349–355 (2011)
2. Hoy, M., Peter, R., Richter, A.: Take-up for genetic tests and ambiguity. J. Risk Insur. 48, 111–133 (2014)
3. National Institute for Health and Care Excellence. Familial breast cancer: classify-cation, care and managing breast cancer and related risks in people with a family history of breast cancer: NICE guidelines. https://www.nice.org.uk/guidance/cg164 (2013)
4. Owens, D.K.: Risk Assessment, genetic counseling, and genetic testing for BRCA-related cancer: US Preventive Services Task Force Recommendation Statement. J. Am. Med. Assoc. 322(7), 652–665 (2019). https://doi.org/10.1001/jama.2019.10987
5. Pauker, S.G., Kassirer, J.P.: The threshold approach to clinical decision making. N. Engl. J. Med. 302(20), 1109–1117 (1980)
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Test and Treatment Decisions;Medical Decision Making;2022